SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-067349
Filing Date
2013-12-16
Accepted
2013-12-16 09:00:59
Documents
11
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v362549_10q.htm 10-Q 374330
2 EXHIBIT 31.1 v362549_ex31-1.htm EX-31.1 10086
3 EXHIBIT 31.2 v362549_ex31-2.htm EX-31.2 10202
4 EXHIBIT 32.1 v362549_ex32-1.htm EX-32.1 5244
5 EXHIBIT 32.2 v362549_ex32-2.htm EX-32.2 5407
  Complete submission text file 0001144204-13-067349.txt   3665685

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lltp-20131031.xml EX-101.INS 479687
7 XBRL TAXONOMY EXTENSION SCHEMA lltp-20131031.xsd EX-101.SCH 39089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lltp-20131031_cal.xml EX-101.CAL 37318
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lltp-20131031_def.xml EX-101.DEF 173104
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lltp-20131031_lab.xml EX-101.LAB 512881
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lltp-20131031_pre.xml EX-101.PRE 267311
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 131277938
SIC: 1000 Metal Mining